Developing localized gene therapies for high-burden cancers
Bridging the gap between survival and quality of life for cancer patients
Gel-Plex Platform
Precision. Localized. Sustained.
Standard chemotherapy is a blunt instrument. In India, over 1.4 million new cancer cases are reported annually, with many patients lacking access to precision medicine due to prohibitive costs and logistical barriers. We are changing that.
We develop gene-based chemotherapeutics (polyplexes) that are loaded into a hydrogel for precision targeting and localized drug delivery.
-
We don't just get the drug to the tumor, we get it into the cell.
-
Our gels respond to the acidic tumor environment (pH 6.5) to release therapy only where it’s needed. Therefore, avoiding off-site toxicity.
Contact Us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!